Laboratorios Farmaceuticos Rovi, S.A.'s latest marketcap:
As of 07/05/2025, Laboratorios Farmaceuticos Rovi, S.A.'s market capitalization has reached $3.38 B. According to our data, Laboratorios Farmaceuticos Rovi, S.A. is the 4382th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 3.38 B |
| Revenue (ttm) | 903.67 M |
| Net Income (ttm) | 164.87 M |
| Shares Out | 51.15 M |
| EPS (ttm) | 3.22 |
| Forward PE | 20.58 |
| Ex-Dividend Date | 07/14/2025 |
| Earnings Date | 07/24/2025 |
Laboratorios Farmaceuticos Rovi, S.A.'s yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 07/05/2025 | €3.38 B | -11.6% | 4382 |
| 12/31/2024 | €3.22 B | 0.22% | 4027 |
| 12/29/2023 | €3.21 B | 66.93% | 3753 |
| 12/30/2022 | €1.92 B | -53.49% | 5267 |
| 12/30/2021 | €4.14 B | 97.1% | 3377 |
| 12/31/2020 | €2.1 B | 55.36% | 4592 |
| 12/31/2019 | €1.35 B | 39.84% | 5381 |
| 12/31/2018 | €966.34 M | 25.21% | 5792 |
| 12/29/2017 | €771.81 M | 26.97% | 7469 |
| 12/30/2016 | €607.86 M | -14.76% | 8518 |
Company Profile
About Laboratorios Farmaceuticos Rovi, S.A.
Laboratorios Farmaceuticos Rovi, S.A. is a pharmaceutical company specializing in the manufacturing, sale, and marketing of pharmaceutical products. Established in 1946 and headquartered in Madrid, Spain, the company operates globally, serving Spain, the European Union, OECD countries, and international markets.
Product Portfolio
Rovi offers a diverse range of pharmaceutical solutions across multiple therapeutic areas:
Prescription Products
- Cardiology & Endocrinology: Ameride, Prinvil, Neparvis
- Central Nervous System: Medicebran, Medikinet, Tryptizol
- Respiratory: Hirobriz Breezhaler, Ulunar Breezhaler
- Women's Health & Osteoarticular: Calcium Vitamine D3 Rovi, Bertanel
- Other Treatments: Rhodogil, Glufan, Mysimba, Orvatez
Hospital Products
- Diagnostic Imaging: Iomeron, Iopamiro, Multihance, Sonovue
- Catheter Care: Fibrilin
- Specialty Injectables: Sodium Heparin Rovi
Contract Manufacturing Services
Rovi provides comprehensive pharmaceutical manufacturing solutions, including:
- Compounding and aseptic filling
- Terminal sterilization and inspection
- Safety device installation and labeling
- Packaging, serialization, and aggregation
The company specializes in injectable forms (prefilled syringes, vials, cartridges) and solid dosage products.
Therapeutic Applications
Rovi's products serve multiple medical specialties:
- Cardiology
- Osteoarticular/Women's Health
- Anesthesia/Pain Management
- Diagnostic Imaging
- Central Nervous System
- Urology
- Endocrinology
- Respiratory
- Primary Healthcare
Parent Company: Norbel Inversiones, S.L.
Frequently Asked Questions
-
What is Laboratorios Farmaceuticos Rovi, S.A.'s (BME-ROVI) current market cap?As of 07/05/2025, Laboratorios Farmaceuticos Rovi, S.A. (including the parent company, if applicable) has an estimated market capitalization of $3.38 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Laboratorios Farmaceuticos Rovi, S.A. (BME-ROVI) rank globally by market cap?Laboratorios Farmaceuticos Rovi, S.A. global market capitalization ranking is approximately 4382 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.